These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 260996)

  • 1. Urinary excretion of prostaglandin E like material and kallikrein: effects of furosemide.
    Halushka PV; Margolius HS; Allen H; Conradi EC
    Prostaglandins; 1979 Sep; 18(3):359-68. PubMed ID: 260996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary kallikrein and prostaglandin response to frusemide in mild hypertension.
    Mackay IG; Watson ML; Nath KA; Cumming AD; Muir AL
    Contrib Nephrol; 1984; 41():160-2. PubMed ID: 6570092
    [No Abstract]   [Full Text] [Related]  

  • 4. Interference of different ACE-inhibitors with the diuretic action of furosemide and hydrochlorothiazide.
    Toussaint C; Masselink A; Gentges A; Wambach G; Bönner G
    Klin Wochenschr; 1989 Nov; 67(22):1138-46. PubMed ID: 2586018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.
    Overlack A; Stumpe KO; Müller HM; Kolloch R; Higuchi M
    Klin Wochenschr; 1982 Oct; 60(19):1223-8. PubMed ID: 6183482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiloride, frusemide and urinary kallikrein excretion.
    Waller DG; Thakrar PM; Campbell SK
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):145-50. PubMed ID: 3446039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of urinary kallikrein excretion to urinary potassium excretion during furosemide administration with and without amiloride.
    Obika LF
    Arch Int Physiol Biochim; 1987 Mar; 95(1):13-8. PubMed ID: 2441670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary prostaglandin and kallikrein excretion are not flow dependent in the rat.
    Fejes-Tóth G; Náray-Fejes-Tóth A; Rigter B; Frölich JC
    Prostaglandins; 1983 Jan; 25(1):99-103. PubMed ID: 6405455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminution by captopril of the diuretic, natriuretic and kallikrein stimulating action of furosemide by reduction in its renal secretion.
    Bönner G; Gentges A; Wambach G; Kaufmann W
    Agents Actions Suppl; 1987; 22():309-19. PubMed ID: 3324714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension.
    Franchi F; Lo Sapio P; Strazzulla G; Fabbri G; Scardi A; Pinzani M; Laffi G; Mannelli M
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):44-9. PubMed ID: 3549580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Furosemide interaction with the prostaglandin and kallikrein-kinin systems of the kidneys].
    Kuz'min OB; Mikhaĭlenko PV; Kriukova RA
    Farmakol Toksikol; 1986; 49(2):21-4. PubMed ID: 2423364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension.
    Abe K; Yasujima M; Chiba S; Irokawa N; Ito T; Yoshinaga K; Saito T
    Prostaglandins; 1977 Sep; 14(3):513-21. PubMed ID: 905575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic and endocrine responses of the kidney to frusemide in mild essential hypertension.
    Mackay IG; Nath K; Cumming AD; Muir AL; Watson ML
    Clin Sci (Lond); 1985 Feb; 68(2):159-64. PubMed ID: 3881208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the renal prostaglandins in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):25-8. PubMed ID: 6587654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prostaglandin E2 excretion with oral kallikrein treatment in hypertensive and normotensive subjects.
    Muller HM; Overlack A; Stumpe KO; Kollock R; Ressel C
    Adv Exp Med Biol; 1983; 156 (Pt B)():1005-9. PubMed ID: 6574693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.